01 Pages : 1-10
http://dx.doi.org/10.31703/gdddr.2024(IX-I).01 10.31703/gdddr.2024(IX-I).01 Published : Mar 2024Global Prevalence and Mortality of Type-2 Diabetes from 1990 to 2019, with Future Projections to 2023 and 2050: a Systematic Review
Type-2 diabetes (T2DM) is a key public health issue due to its high prevalence and mortality rate. This review estimates future global trends in T2DM prevalence and mortality using the Forecast exponential smoothing (ETS) model. By 2050, estimated prevalence and mortality for all ages are 10.23% and 2.05 million, respectively, and for adults (>20 years) are 11.97% and 1.9 million. Obesity and high BMI are key risk factors. Mortality is higher in adults due to polypharmacy and complications. T2DM prevalence and mortality will continue to rise alarmingly. Urgent international and national measures are needed to address this burden. Collaboration between researchers, clinicians, and policymakers is crucial for optimal health planning and mitigating the impact of T2DM.
-
Type-2 Diabetes, Prevalence, Mortality, Forecast
-
(1) Hafiz Muhammad Usman Abid
Assistant Professor, Tahseen Ahmad Cheema Institute, Bahawalpur, Punjab, Pakistan.
(2) Muhammad Hanif
Associate Professor, Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Punjab, Pakistan.
(3) Muhammad Naveed Bin Afzal
Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Punjab, Pakistan.
(4) Muhammad Azeem
Hamdard Institute of Pharmaceutical Sciences, Hamdard University Islamabad, Pakistan.
(5) Dur e Shahwar
Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Punjab, Pakistan.
(6) Khalid Mahmood
Associate Professor, Institute of Chemical Sciences, Bahauddin Zakariya University Multan, Punjab, Pakistan.
Cite this article
-
APA : Abid, H. M. U., Hanif, M., & Afzal, M. N. B. (2024). Global Prevalence and Mortality of Type-2 Diabetes from 1990 to 2019, with Future Projections to 2023 and 2050: a Systematic Review. Global Drug Design & Development Review, IX(I), 1-10. https://doi.org/10.31703/gdddr.2024(IX-I).01
-
CHICAGO : Abid, Hafiz Muhammad Usman, Muhammad Hanif, and Muhammad Naveed Bin Afzal. 2024. "Global Prevalence and Mortality of Type-2 Diabetes from 1990 to 2019, with Future Projections to 2023 and 2050: a Systematic Review." Global Drug Design & Development Review, IX (I): 1-10 doi: 10.31703/gdddr.2024(IX-I).01
-
HARVARD : ABID, H. M. U., HANIF, M. & AFZAL, M. N. B. 2024. Global Prevalence and Mortality of Type-2 Diabetes from 1990 to 2019, with Future Projections to 2023 and 2050: a Systematic Review. Global Drug Design & Development Review, IX, 1-10.
-
MHRA : Abid, Hafiz Muhammad Usman, Muhammad Hanif, and Muhammad Naveed Bin Afzal. 2024. "Global Prevalence and Mortality of Type-2 Diabetes from 1990 to 2019, with Future Projections to 2023 and 2050: a Systematic Review." Global Drug Design & Development Review, IX: 1-10
-
MLA : Abid, Hafiz Muhammad Usman, Muhammad Hanif, and Muhammad Naveed Bin Afzal. "Global Prevalence and Mortality of Type-2 Diabetes from 1990 to 2019, with Future Projections to 2023 and 2050: a Systematic Review." Global Drug Design & Development Review, IX.I (2024): 1-10 Print.
-
OXFORD : Abid, Hafiz Muhammad Usman, Hanif, Muhammad, and Afzal, Muhammad Naveed Bin (2024), "Global Prevalence and Mortality of Type-2 Diabetes from 1990 to 2019, with Future Projections to 2023 and 2050: a Systematic Review", Global Drug Design & Development Review, IX (I), 1-10
-
TURABIAN : Abid, Hafiz Muhammad Usman, Muhammad Hanif, and Muhammad Naveed Bin Afzal. "Global Prevalence and Mortality of Type-2 Diabetes from 1990 to 2019, with Future Projections to 2023 and 2050: a Systematic Review." Global Drug Design & Development Review IX, no. I (2024): 1-10. https://doi.org/10.31703/gdddr.2024(IX-I).01